Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
PresidentDonald TrumpOn Monday, a 30-day order for pharmacies signed, lower the price of prescription medications in the United States or has a new limit on the government.
The order calls for the head of healthRobert F. Kennedy Jr.New price labels for medicines for the next month to the broker. If the transactions do not reach, Kennedy will be instructed to prepare a new rule on the payment of drugs for drugs due to low prices for the prices of other countries.
“We will equate,” Trump said during a press conference on Monday morning. “We will all pay the same. We will pay for what Europe pays.”
It is not clear what – if any effect – the executive order of the President of the Republic will affect millions of Americans with private health insurance. The federal government has the most power to pay for medicare covered by Medicare and Medicaid.
Trump’s promised new – but uncertain – saving drug prices, released several hours after the Republic-LED houseNew plan to start Medicaid $ 880 billion.
Taxpayers spendHundreds of dollars dollarsAbout recipe medications, transfusions and other medications via Medicare covering 70 million ages every year. Medicaid providing almost 80 million poor and disabled people in the United StatesTenses ten billions of dollarsfor drugs each year.
They say the best media of the United States is bad for the patients of the Trump’s order
The pharmaceutical lobby of the nation, which represents the best medicine medicines, immediately called the “bad deal” for American patients and opposed the Trump’s command. Pharmacies have claimed that any threat on their earnings can affect the investigation into developing new drugs.
“Imports of foreign prices from socialists would be a bad deal for American patients and employees,” President of PHRMA President Stephen J. UBL and PHRMA and Director General. “It would mean less treatment and treatment and hundreds of billions of billions plan to invest in America.”
Medicare is controversial for the so-called “most popular nation” for drug prices, because it is controversial because it is trying to implement it within the first term. SignedA similar executive procedureIn the last weeks of the presidency called to the United States, only other countries pay for some medications – such as infusion or cancer medications as managed questions or cancer drugs.
This narrow proceedings have faced obstaclesCourt orderThis rule prevented the President Joe Biden from entering into force. The pharmaceutical industry claimed that the top side of the 2020 “Top hand” to determine the cost of Trump’s 2020 attempts in the United States
Trump says other countries will blame
Trump has repeatedly defended pharmaceutical companies, instead, instead, the Americans pay for drugs at a high price during a wide speech on Monday. President Kennedy, Medicare and Medicaid Services Administrator, Food and Medicinal Administration Commissioner Dr. Marty Makary and National Health Director Jay Bhattacharya Murder by National Institutions.
At the same time, the federal investigations threatened to practices and threatened the US drug market to bring more imported drugs than other countries.
“Pharmaceutical companies do most of their earnings from America,” he said. “It’s not a good thing.”
Trump played the announcement of the weekend, boasting the plan’s “can save dollars with trillions”.
However, on Monday, the White House has provided no features to how much money management has earned.
The highest leaders of the health department will meet with drug company executors for the next 30 days, and on Monday, OZ told me to offer new prices to what other countries pay.
It is impossible to see the immediate savings of Americans
Americans said that due to the order of ordering quickly, Rachel Sachs, the University of Washington, the probability of the desire to desire to quickly.
“Indeed, it is not to ask for voluntarily to ask the prices of manufacturers voluntarily, asking voluntarily to a unknown point,” Sachs said. “If they do not reduce their prices to the desired point, the HHS will take other actions with a very long schedule, while others have years, lower drug prices.”
The Health Department has the most authority to change the prices of medications covered by Medicare and Medicaid. Still, the agency is limited to do so. Congress only confirmed in 2022a new lawMedicare allows you to pay for several recipe medicines that allow you to pay the money to pay for a handful of recipe medicines starting in 2026, starting in 2026. Drug companies have failed to the implementation of the law.
Price of millions of Americans by personal insurancetake medicineThe agency manipulating is even harder.
The United States regularly compared to other large and wealthy countries, compared to other large and wealthy countries, other peoples, other peoples, but a potential of both major political parties, but a sustainable adjustment did not clear any congress.
Trump, pharmaceutical companies entered the first term of the government and the first term of the government that the governments benefited from the Americans.
Trump says ‘will do the right thing’
In front of the announcement, Trump, “Pharmaceutical / drug companies have been research and development and all of these costs, not only” American ‘suctions’, not only, not only, not only, only, not only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, only, not only, only, not only.
Touching on the strong lobby efforts of drug companies, the campaign contributions could “do miracles, but not with me, not me, not with me, and not with me.”
“We will do the right thing,” he said.
Several pharmaceutical companies won land on Monday morning. MerckA company, which amounted to $ 64.2 billion last year, skipped cancer treatment in a culit, 3.9%. Pharma giant PfizerIn 2024, $ 63.6 billion in $ 63.6 billion increased by 2.5% Gilead Science rose 5.8%.
This story was first displayed Fortune.com
Source link
